Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
europe
2
×
biotech
boehringer ingelheim
clinical trials
eli lilly
empagliflozin
europe blog main
europe top stories
fda
indiana blog main
indiana top stories
life sciences
national blog main
new york blog main
new york top stories
slgt2 inhibitor
tc
type 1 diabetes
type 2 diabetes
What
expand
2
×
approval
berlin
bid
boehringer
burgeoning
cannabis
capital
completed
demecan
diabetes
drug
eli
euros
facility
fallen
fda
financing
german
germany
germany’s
hit
industry
ingelheim
investor
leads
lilly
marketed
medical
medicine’s
meet
milestone
million
new
patients
production
rejects
round
series
short
Language
unset
Current search:
expand
×
europe
×
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@techcrunch.com
4 years ago
German tech investor leads Series A for Germany’s first medical Cannabis startup